Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2005
10/06/2005WO2005093429A2 Method for the detection of intracellular parameters with luminescent protein probes for the screening of molecules capable of altering said parameters
10/06/2005WO2005093428A2 Chemokine ccl18 as a biomarker
10/06/2005WO2005093427A1 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 50 (gpr50)
10/06/2005WO2005093426A2 Diagnostics and therapeutics for diseases associated with retinoic acid receptor alpha (rara)
10/06/2005WO2005093425A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 58 (gpr58)
10/06/2005WO2005093424A1 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 57 (gpr57)
10/06/2005WO2005093423A2 Diagnostics and therapeutics for diseases associated with peroxisome proliferative activated receptor alpha (ppara)
10/06/2005WO2005093422A2 Carbohydrate-encapsulated quantum dots for biological imaging
10/06/2005WO2005093421A1 Enzyme immunoassay for identifying cathepsin k
10/06/2005WO2005093420A1 Method of monitoring microbe causing infectious disease of experimental animal
10/06/2005WO2005093419A1 Methods and biochips for detecting small molecule compounds
10/06/2005WO2005093418A1 Method of specifically detecting test substance by using photocurrent and electrodes, measurement cell, measurement device and buffer solution to be used therefor
10/06/2005WO2005093417A1 Assays for amphetamine and methamphetamine using stereospecific reagents
10/06/2005WO2005093416A1 Substrate for disposing beads and bead disposing method using the same
10/06/2005WO2005093415A1 Method of assaying apolipoprotein b-48 and use thereof
10/06/2005WO2005093414A2 Assay devices utilizing chemichromic dyes
10/06/2005WO2005093413A2 Diagnosis and treatment of preeclampsia
10/06/2005WO2005093412A1 Method of diagnosing apoplectic stroke/asymptomatic brain infarction using polyamine and acrolein contents, polyamine oxidase activity or protein content thereof as indication
10/06/2005WO2005093411A2 Assays for identifying modulators of the hydroxylation of ankyrin repeat proteins by 2-oxoglutarate dependent oxigenase and methods of using the same
10/06/2005WO2005093410A1 Optical measuring equipment
10/06/2005WO2005093409A1 Method for the in vitro determination of cellular uptake of exogenous and endogenous substances using nmr shift agents and the magic angle nmr technique
10/06/2005WO2005093408A1 Method of diagnosing the chances of pregnancy and the diagnostic kit for the same
10/06/2005WO2005093407A1 Method and apparatus for pre-treating polynuclear aromatic hydrocarbon before analyzing
10/06/2005WO2005093402A1 Method of analyzing dioxins
10/06/2005WO2005093400A1 Fuel cell type wireless enzyme sensor
10/06/2005WO2005093387A1 Sampling single phase from multiphase fluid
10/06/2005WO2005093368A1 Apparatus for detecting joints in rubber sheets
10/06/2005WO2005093103A2 Development and use of fluorescent probes of unbound analytes
10/06/2005WO2005093102A2 Array print buffers
10/06/2005WO2005093098A1 Differential drug sensitivity
10/06/2005WO2005093092A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 44 (gpr44)
10/06/2005WO2005093091A2 Diagnostics and therapeutics for diseases associated with g-protein coupled receptor 26 (gpr26)
10/06/2005WO2005093088A1 Pyrophosphoric acid quantification method, primer extension detection method and apparatus for performing these methods
10/06/2005WO2005093086A1 Method for screening agents modulating a lkb$g(a) protein ubiquitination and means for carrying out said method
10/06/2005WO2005093083A1 Method of disease prediction and method of using the same
10/06/2005WO2005093082A1 Method of screening compound capable of accelerating or inhibiting apoptosis, apoptosis accelerator and apoptosis inhibitor
10/06/2005WO2005093076A1 Method of separating precusror cells of liver cells, endothelial cells or hematopoietic cells from cell mass
10/06/2005WO2005093068A1 Novel protein and promoter
10/06/2005WO2005093066A1 Marker gene for arthrorheumatism test
10/06/2005WO2005093063A1 Kit for solid cancer diagnosis and medicine for solid cancer therapy
10/06/2005WO2005093062A1 Genetic markers usable in breeding beer barley and utilization of the same
10/06/2005WO2005093061A1 METHOD OF ANALYZING PANCREATIC β-CELL AMOUNT AND/OR PANCREATIC β-CELL FUNCTION AND UTILIZATION THEREOF
10/06/2005WO2005093059A1 Primer and primer set for detecting and discriminating yeast, lactic acid bacterium and obligate anaerobe and detection/discrimination method using the same
10/06/2005WO2005093057A1 Truncated dance, dance complex and method of using these
10/06/2005WO2005093051A1 INACTIVE Ca2+/CALMODULIN-DEPENDENT PROTEIN KINASE IIα KNOCKIN ANIMAL AND KNOCKIN CELL OF THE SAME
10/06/2005WO2005093048A1 Cancerous disease modifying antibodies
10/06/2005WO2005093045A2 Cell concentration and pathogen recovery
10/06/2005WO2005092926A2 Reducing the risk of human and anti-human antibodies through v gene manipulation
10/06/2005WO2005092910A1 Labelling reagents, methods for the synthesis of such reagents and methods for the detection of biological molecules
10/06/2005WO2005092831A1 Assays for amphetamine and methamphetamine
10/06/2005WO2005092443A1 Treatment of neurodegenerative diseases by the use of laptm4b
10/06/2005WO2005092377A1 Cytotoxicity mediation of cells evidencing surface expression of cd63
10/06/2005WO2005092376A1 Cytotoxicity mediation of cells evidencing surface expression of mcsp
10/06/2005WO2005092375A1 Cytotoxicity mediation of cells evidencing surface expression of cd44
10/06/2005WO2005092316A1 Novel pharmaceutical compositions comprising agonists of the thyroid receptor
10/06/2005WO2005092114A2 Compositions and methods for destruction of prion infectious proteins
10/06/2005WO2005092090A1 Obesity model animal and drug evaluation method using the same
10/06/2005WO2005092058A2 Methods for detecting deficient cellular membrane tightly bound magnesium for disease diagnoses
10/06/2005WO2005091969A2 Pre-symptomatic markers for diseases associated with transmissible spongiform encephalopathies
10/06/2005WO2005091956A2 In vitro test system for predicting patient tolerability of therapeutic agents
10/06/2005WO2005091704A2 Magnetic nanoparticles of noble metals
10/06/2005WO2005083425A3 Diagnostics and therapeutics for diseases associated with mitogen-activated protein kinase kinase kinase 13 (map3k13)
10/06/2005WO2005080939A3 Method and device for detecting feline immunodeficiency virus
10/06/2005WO2005077090A3 Improved methods of producing antibody conjugates
10/06/2005WO2005075990A3 Diagnostics and therapeutics for diseases associated with human nuclear receptor nr4a2 (nr4a2)
10/06/2005WO2005075983A3 Diagnostics and therapeutics for diseases associated with human nuclear receptor nr4a3 (nr4a3)
10/06/2005WO2005074572A3 Methods and compositions for detecting of equine tapeworm infections
10/06/2005WO2005074541A3 Detection of biological and chemical agents
10/06/2005WO2005072066A3 Preventive or therapeutic agent for diabetic maculopathy
10/06/2005WO2005069000A3 Methods of identifying cytotoxic effects in quiescent cells
10/06/2005WO2005056814A3 Methods and systems for analyzing and determining ligand-residue interaction
10/06/2005WO2005056751A3 Apparatus and method for concentrating stem cell
10/06/2005WO2005054867A3 Diagnostics and therapeutics for diseases associated with potassium channel, subfamily k, member 5 (kcnk5)
10/06/2005WO2005052588A3 Detection of protein interactions
10/06/2005WO2005049862A3 Method for analysis by molecular hybridation of nucleic acids and kit for carrying out said method
10/06/2005WO2005049838A3 Syk-targeted nucleic acid interference
10/06/2005WO2005042559A3 Capture and release based isotope tagged peptides and methods for using the same
10/06/2005WO2005039588A3 Methods for determining the risk of developing liver and lung toxicity
10/06/2005WO2005034876A3 Use of cell lines to produce active therapeutic proteins
10/06/2005WO2005026730A3 Multiplex binding and activity assays
10/06/2005WO2005026719A3 Diagnostics and therapeutics for diseases associated with transporter slc22a3 (slc22a3)
10/06/2005WO2005024065B1 Cationic dye compound for detecting nucleic acid double strand, and detection method and apparatus using same
10/06/2005WO2005022167A3 Compounds that act to modulate insect growth and methods and systems for identifying such compounds
10/06/2005WO2005017121A3 Mbcats as modifiers of the beta-catenin pathway and methods of use
10/06/2005WO2005007097A3 Breast cancer genes
10/06/2005WO2005002551A3 Vanilloid receptor (vr) 1 inhibitors for treatment of human immunodeficiency virus (hiv)-mediated pain states
10/06/2005WO2004094609A3 Methods for characterizing signaling pathways and compounds that interact therewith
10/06/2005WO2004094603A3 Transgenic mouse with simplified dh locus
10/06/2005WO2004084800A3 A3 receptor-mediated cardioprotective proteins and therapeutic and diagnostic methods of use
10/06/2005WO2004081531A8 Ligand analysis
10/06/2005WO2004065933A3 Method and apparatus for enhanced detection of a specie using a gas chromatograph
10/06/2005WO2004059279A3 High-sensitivity assays for pathogen detection using metal-enhanced fluorescence
10/06/2005WO2004041752A3 Chemical encoding technology for combinatorial synthesis
10/06/2005WO2004041193A3 HUMAN TYPE II DIABETES GENE-Kv CHANNEL-INTERACTING PROTEIN (KChIP1) LOCATED ON CHROMOSOME 5
10/06/2005WO2004032877A3 Compositions, organisms and methodologies employing a novel human kinase
10/06/2005WO2004009016A3 Compositions and methods involving nuclear hormone receptor site ii
10/06/2005US20050223109 Data integration through a services oriented architecture
10/06/2005US20050222931 Real time data integration services for financial information data integration
10/06/2005US20050222783 Measuring and sensor assembly for determining a characteristic of a fluid and method for operating the same
10/06/2005US20050222779 Detecting recessive diseases in inbred populations
1 ... 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2034 2035 2036 2037 2038 2039 2040 ... 3937